Form4insider filings, from the source

SEC Form 4 · accession 0001012975-15-000646

Global Blood Therapeutics, Inc. · GBT

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Mark J Levin
10% Owner
Period of report
Aug 17, 2015
Accepted (ET)
Aug 19, 2015 · 4:31 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001629137

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2,F3Aug 17, 2015C2,285,713—A2,285,713D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Series A Preferred StockF3,F1,F2—Aug 17, 2015C8,000,000D——Common Stock8,000,0000D

Explanation of responses